POSITION STATEMENTS
Important Messages from AES
An Important Message from the American Epilepsy Society on Healthcare Equity and Troubled Times
Position Statements
Telehealth Position Statement, September 29, 2020
Position Statement on SUDEP Counseling (This position statement is endorsed by the Child Neurology Foundation)
Position Statement on the Use of Valproate by Women of Childbearing Potential
American Epilepsy Society Position on Cannabis as a Treatment for Epileptic Seizures
American Epilepsy Society Calls for Immediate Access to Accepted Treatments for Infantile Spasms
Substitution of Different Formulations of Antiepileptic Drugs for the Treatment of Epilepsy
Benzodiazepine Use and Epilepsy
Comments/Letters
AES endorses the concept of an FDA-sponsored set of networks for rare disease clinical trials [PDF] (July 31, 2020)
AES comments to the NINDS on developing an online educational resource for training in the principles of rigorous research [PDF] (July 31, 2020)
AES comments to the NINDS on areas of health disparities and inequities in neurological disease and/or care [PDF] (June 15, 2020)
AES Comments on Therapeutic Substitution of Medications [PDF]
AES letters in opposition to CMS proposed changes to coding and reimbursement of evaluation and management (E/M) services:
- AMA/AES letter of opposition to CMS proposed changes
- AES/AAN letter of opposition to CMS proposed changes
- AES/NAEC letter of opposition to CMS proposed changes
Template Letter for LITT Insurance Denial
AES Sign-on to AMA Letter to Congress Regarding "Surprise Billing" Legislation